World's Best Scientists 2026 revealed!
Filomeen Haerynck

Filomeen Haerynck

D-Index & Metrics

Immunology

D-Index
47
Citations
13594
World Ranking
4470
National Ranking
74

Overview

Filomeen Haerynck is affiliated with Ghent University in Belgium and has a research focus spanning medicine, immunology, microbiology, biochemistry, genetics, and molecular biology. Their work notably intersects several subfields, including immunology, infectious diseases, molecular biology, genetics, and surgery.

The scientist has contributed to the understanding of immunodeficiency and autoimmune disorders, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, Kawasaki disease and coronary complications, interferon and immune responses, diabetes and associated disorders, as well as respiratory viral infections research.

Haerynck's recent published papers include:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19, 2020, Science
  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, 2020, Science
  • Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths, 2021, Science Immunology
  • Multisystem inflammatory syndrome in children related to COVID-19: a systematic review, 2021, European Journal of Pediatrics
  • Human genetic and immunological determinants of critical COVID-19 pneumonia, 2022, Nature

Frequent co-authors with significant collaboration counts include Simon J. Tavernier, Levi Hoste, Paul Bastard, Isabelle Meyts, and Tayfun Özçelık.

Their work is often published in journals such as The Journal of Experimental Medicine, Frontiers in Immunology, Journal of Allergy and Clinical Immunology, bioRxiv (Cold Spring Harbor Laboratory), and Journal of Clinical Immunology.

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries

    Ludovic de Beaucoudrey;Arina Samarina;Arina Samarina;Arina Samarina;Jacinta Bustamante;Jacinta Bustamante;Aurélie Cobat;Aurélie Cobat

  • Multisystem inflammatory syndrome in children related to COVID-19: a systematic review.

    Levi Hoste;Ruben Van Paemel;Filomeen Haerynck

  • Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP-deficiency)

    Jana Pachlopnik Schmid;Jana Pachlopnik Schmid;Danielle Canioni;Despina Moshous;Despina Moshous;Fabien Touzot

  • Genes associated with common variable immunodeficiency: one diagnosis to rule them all?

    Delfien J A Bogaert;Melissa Dullaers;Bart N Lambrecht;Karim Y Vermaelen

  • Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study

    Federica Barzaghi;Laura Cristina Amaya Hernandez;Benedicte Neven;Silvia Ricci

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

    Unknown

  • Familial Mediterranean Fever Mutations Lift the Obligatory Requirement for Microtubules in Pyrin Inflammasome Activation

    Hanne Van Gorp;Pedro Henrique Viana Saavedra;Nathalia Moraes de Vasconcelos;Nina Van Opdenbosch

  • Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score

    Victoria Katharina Tesch;Hassan Abolhassani;Hassan Abolhassani;Bella Shadur;Bella Shadur;Joachim Zobel

  • Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation

    Aude Magerus-Chatinet;Bénédicte Neven;Marie Claude Stolzenberg;Cécile Daussy

  • Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

    Julian Thalhammer;Gerhard Kindle;Alexandra Nieters;Stephan Rusch

  • Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    Unknown

  • SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Vanessa Sancho-Shimizu;Petter Brodin;Aurélie Cobat;Aurélie Cobat;Aurélie Cobat;Catherine M Biggs

  • Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.

    Yehudi Bloch;Laura Bouchareychas;Laura Bouchareychas;Romain Merceron;Katarzyna Składanowska

  • Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis.

    Scott B Drutman;Filomeen Haerynck;Franklin L Zhong;David Hum

  • X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world

    Zeinab A. El-Sayed;Irina Abramova;Juan Carlos Aldave;Waleed Al-Herz

  • Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

    Béziat;Tavernier Sj;Chen Yh;Ma Cs

  • Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency.

    Ana Karina Alves de Medeiros;Evelyn Lodewick;Delfien J A Bogaert;Filomeen Haerynck

  • TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

    Levi Hoste;Lisa Roels;Leslie Naesens;Victor Bosteels

  • Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

    Jozefien Declercq;Karel F A Van Damme;Elisabeth De Leeuw;Bastiaan Maes

Frequent Co-Authors

Bart N. Lambrecht
Bart N. Lambrecht Ghent University
Laurent Abel
Laurent Abel Université Paris Cité
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Elfride De Baere
Elfride De Baere Ghent University
Emmanuelle Jouanguy
Emmanuelle Jouanguy Necker-Enfants Malades Hospital
Aurélie Cobat
Aurélie Cobat Grenoble Alpes University
Aurora Pujol
Aurora Pujol Institut d'Investigació Biomédica de Bellvitge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can provide valuable career options. Programs like Licensed Practical Nurse (LPN) pathways offer a practical entry into healthcare with fewer barriers. If you are seeking programs with less competitive admissions, check out the easiest lpn programs to get into.

Nursing roles, especially Nurse Practitioners, often specialize in areas like immunological disorders or mental health. For professionals aiming to advance quickly, understanding which nurse practitioner program is easiest can help streamline the education process without sacrificing quality.

Mental health is closely linked to immunology through inflammation and neurological pathways. If you want to specialize further, consider the best online psychiatric mental health nurse practitioner programs that provide reliable clinical placements essential for hands-on experience.

Cost is also a significant factor when selecting an advanced degree, especially in specialized fields. For budget-conscious students, exploring the cheapest pmhnp programs can offer financial relief while pursuing a meaningful healthcare career.

Best Scientists Citing Filomeen Haerynck

Trending Scientists

Recently Published Articles